KyungDong Pharm home
Prescription Medicines

Penium-S Tab.

Product Category
Treatment for acute bronchitis
Active Ingredients
Pelargonium sidoides 11% ethanol dried extract (5.5~6.6→1)
Appearance
Reddish-brown, round, film-coated tablets
Reimbursement Code
648104290
View Regulatory Information on the MFDS Portal ↗
1. Composition and Strength : 1 tablet
- Active ingredient: Pelargonium sidoides 11% ethanol dried extract (5.5~6.6→1) (in-house specification) --- 20mg
- Additives: Microcrystalline cellulose, Opadry 200 Red 200F250000, sodium starch glycolate, colloidal silicon oxide, sodium stearyl fumarate

2. Efficacy/Effectiveness
acute bronchitis

3. Usage/Dosage
Adults and over 12 years of age: Take 1 tablet at a time, 3 times a day, with a small amount of water.

4. Precautions for use
1. Do not administer to the following patients.
1) Pregnant and lactating women
2) Patients with increased bleeding tendency, patients taking anticoagulants
3) Patients with severe liver disease and renal disease
4) Patients with hypersensitivity to the ingredients of this drug
5) Children under 12 years of age

2. Adverse reactions
1) Occasionally, gastrointestinal disorders such as stomach pain, heartburn, nausea, and diarrhea may occur.
2) In rare cases, mild gum bleeding or epistaxis may occur.
3) In rare cases, hypersensitivity reactions such as rash, hives, and itching of the skin and mucous membranes may occur.
4) In very rare cases, severe hypersensitivity reactions such as facial edema, difficulty breathing, and decreased blood pressure may occur.
5) Occasionally, liver levels may increase, and some patients may show inflammation-related liver disease.
6) A decrease in platelet count was observed while taking this drug. However, this may be caused by an underlying disease.
7) The results of domestic post-marketing surveillance for liquid and syrup products with the same ingredients are as follows.
: As a result of the safety evaluation conducted on 641 people during the post-marketing surveillance period in Korea, the incidence of adverse events was 0.47% (3 people/641 people, 3 cases) regardless of causal relationship, and there were no adverse drug cases for which a causal relationship with this drug could not be ruled out. Among the adverse events reported, there were no serious adverse events or unexpected adverse drug reactions.
8) Reported cases of adverse drug reactions overseas for liquids and syrups with the same ingredients are as follows.
: Cases of liver damage and hepatitis have been reported in foreign countries related to the use of this drug. Because these cases were reported voluntarily, no reliable incidence rates could be derived.

3. General precautions
1) If signs of liver damage (jaundice, dark urine, severe upper abdominal pain, loss of appetite) appear related to taking this drug, stop taking it immediately.
2) If the condition does not improve within one week, fever persists for several days, or conditions such as difficulty breathing or bloody sputum do not improve, stop taking the medication.
3) Do not take in a lying position.

4. Interaction
No interactions with other medicines have been reported to date. Because this medicine may affect coagulation factors, an enhanced anticoagulant effect cannot be ruled out when it is used with coumarin anticoagulants such as phenprocoumon or warfarin. A clinical study in healthy subjects found no interaction between this medicine and penicillin V.

5. Administration to pregnant and lactating women
Because its safety for pregnant and lactating women has not been established, it is advisable not to administer to pregnant or lactating women.

6. Treatment in case of overdose
There have been no reported cases of overdose yet, but as adverse reactions are likely to increase, consult a doctor in case of overdose.

7. Storage and handling precautions
1) Be careful to keep it out of reach of children.
2) Be careful as changing it to another container may cause an accident or is undesirable in terms of maintaining quality.
3) The effect on driving and operating machinery is unknown.

5. How to save
Airtight container, stored at room temperature (1~30℃)

6. Packaging unit
30 tablets/bottle, 300 tablets/bottle

7. Period of use
36 months from date of manufacture